Clinical Value of High Mobility Group Box 1 and the Receptor for Advanced Glycation End-products in Head and Neck Cancer: A Systematic Review
Abstract Introduction High mobility group box 1 is a versatile protein involved in gene transcription, extracellular signaling, and response to inflammation. Extracellularly, high mobility group box 1 binds to several receptors, notably the receptor for advanced glycation end-products....
Main Authors: | Austin Nguyen, Sheila Bhavsar, Erinn Riley, Gabriel Caponetti, Devendra Agrawal |
---|---|
Format: | Article |
Language: | English |
Published: |
Thieme Revinter Publicações Ltda.
2016-04-01
|
Series: | International Archives of Otorhinolaryngology |
Subjects: | |
Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0036-1583168 |
Similar Items
-
Association of high mobility group BOX-1 and receptor for advanced glycation endproducts with clinicopathological features of haematological malignancies: a systematic review
by: Austin H. Nguyen, et al.
Published: (2017-01-01) -
Protein Post-translational Modifications in Head and Neck Cancer
by: Hongbo Zhang, et al.
Published: (2020-09-01) -
Overexpression of High-Mobility Motor Box 1 in the Blood and Tissues of Patients with Head and Neck Squamous Cell Carcinoma
by: Farnaz Mohajertehran, et al.
Published: (2018-09-01) -
Autoimmune response to advanced glycosylation end-products of human LDL
by: Gabriel Virella, et al.
Published: (2003-03-01) -
Targeting advanced glycation end products in cardiac surgery: The unexplored alternative
by: Antonio Nenna, et al.
Published: (2016-01-01)